|Articles|November 9, 2021
- Pharmaceutical Executive-11-01-2021
- Volume 41
- Issue 11
Pharmaceutical Executive, November 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive November 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 4 years ago
In It For the Long-Haul: Planning for the Future of COVID-19about 4 years ago
Turning the Corner: A New Era of Pharma Sales Comes Into Viewabout 4 years ago
The New COVID Workforce: Keeping Pharma Strong Through Adversityabout 4 years ago
Crafting Curesabout 4 years ago
Could 2022 Prove to Be Better Year for Biotech Companies?about 4 years ago
COVID and the Data Talent Turnaboutabout 4 years ago
Talent Pipelines Can Position Companies for Greater Hiring Successabout 4 years ago
EU MEPs Arrive At Crossroads in Cancer Strategyabout 4 years ago
Pharm Exec at 40 (2015-2018)Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
